Related Experiment Video
Updated: Jan 19, 2026
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
Mostafa Heidari1,2, Farsad Noorizadeh3, Kevin Wu4,5
1Basir Eye Health Research Center, Tehran 1418643561, Iran. mostafahaidari70@yahoo.com.
Abstract:
Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches, including immunometabolic analyses, microbiome analyses, and bioengineering. Furthermore, we have seen new developments in clinical assessment approaches and treatment strategies in the recent past. Here, we review the emerging frontiers in the pathobiology and clinical management of DED.
Related Concept Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
05:26Press Needle: A Traditional Chinese Medicine Therapy for Myopia Patients with Dry Eye
23:53Ole Isacson: Development of New Therapies for Parkinson's Disease
05:57Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
02:54Performing Injection into Palpebral Portion of the Superior Lacrimal Gland: A Technique for Inducing Dry Eye Disease in Rabbit Model